\uff5e \u4e16\u754c\u3067\u6700\u3082\u9769\u65b0\u7684\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u304c<\/p>\n
\u533b\u85ac\u54c1\u958b\u767a\u306e\u8fc5\u901f\u5316\u306b\u95a2\u3059\u308b\u4e8b\u4f8b\u3092\u7d39\u4ecb \uff5e<\/p>\n
<\/p>\n
2020\u5e745\u670812\u65e5<\/p>\n
³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ) \u306f\u30012020 ³Ô¹Ï±¬ÁÏ R&D Summit Europe<\/a><\/strong>\u30925\u670819\u3001 20\u3001 26\u65e5\u306e3\u65e5\u9593\u306b\u308f\u305f\u308a\u30aa\u30f3\u30e9\u30a4\u30f3\u30a4\u30d9\u30f3\u30c8\u3068\u3057\u3066\u958b\u50ac\u3057\u307e\u3059\u3002\u3053\u306e\u30a4\u30d9\u30f3\u30c8\u306f\u6bce\u5e74\u5b9f\u65bd\u3055\u308c\u3066\u304a\u308a\u3001\u4eca\u56de\u30676\u56de\u76ee\u3092\u8fce\u3048\u307e\u3059\u304c\u3001\u30d9\u30b9\u30c8\u30d7\u30e9\u30af\u30c6\u30a3\u30b9\u306e\u5171\u6709\u3084\u696d\u754c\u3067\u306e\u4eba\u8108\u3065\u304f\u308a\u3092\u76ee\u7684\u3068\u3057\u30661,000\u540d\u3092\u8d85\u3048\u308b\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306b\u7cbe\u901a\u3057\u305f\u5c02\u9580\u5bb6\u3084\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u306e\u53c2\u52a0\u304c\u898b\u8fbc\u307e\u308c\u3066\u304a\u308a\u3001AstraZeneca\u793e\u3001Merck KGaA\u793e\u3001LEO Pharma\u793e\u3001Idorsia\u793e\u3092\u306f\u3058\u3081\u3068\u3059\u308b\u5927\u624b\u30b0\u30ed\u30fc\u30d0\u30eb\u88fd\u85ac\u4f01\u696d\u304b\u3089\u65b0\u8208\u30d0\u30a4\u30aa\u4f01\u696d\u307e\u306770\u540d\u3092\u8d85\u3048\u308b\u30b9\u30d4\u30fc\u30ab\u30fc\u306b\u3088\u308b\u8b1b\u6f14\u304c\u884c\u308f\u308c\u308b\u4e88\u5b9a\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n <\/p>\n \u57fa\u8abf\u8b1b\u6f14\u8005\u306b\u306f\u3001\u7cd6\u5c3f\u75c5\u306a\u3069\u306e\u6df1\u523b\u306a\u6162\u6027\u75be\u60a3\u306b\u7279\u5316\u3057\u305f\u30b0\u30ed\u30fc\u30d0\u30eb\u30d8\u30eb\u30b9\u30b1\u30a2\u4f01\u696d\u3067\u3042\u308bNovo Nordisk\u793e\u306e\u30b7\u30cb\u30a2\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3067\u3042\u308bRobin Evers\u6c0f\u3092\u8fce\u3048\u3001\u540c\u793e\u306b\u304a\u3051\u308b\u7814\u7a76\u958b\u767a\u5168\u4f53\u3067\u306e\u4e00\u8cab\u3057\u305f\u7d71\u5408\u30d7\u30ed\u30bb\u30b9\u306b\u57fa\u3065\u304f\u533b\u85ac\u54c1\u958b\u767a\u306e\u8fc5\u901f\u5316\u306b\u95a2\u3059\u308b\u4e8b\u4f8b\u306e\u307b\u304b\u3001\u4e16\u754c\u304c\u30d1\u30f3\u30c7\u30df\u30c3\u30af\u306b\u9665\u3063\u3066\u3044\u308b\u73fe\u5728\u3001\u60a3\u8005\u306b\u6cbb\u7642\u3092\u5c4a\u3051\u308b\u305f\u3081\u306b\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u3067\u306f\u3069\u306e\u3088\u3046\u306a\u5354\u529b\u4f53\u5236\u3092\u6577\u3044\u3066\u3044\u308b\u306e\u304b\u3092\u8a9e\u3063\u3066\u3044\u305f\u3060\u304d\u307e\u3059\u3002<\/p>\n \u4eca\u5e74\u306e\u30a2\u30b8\u30a7\u30f3\u30c0\u3067\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u3068\u6700\u9069\u5316\u3001\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306e\u5411\u4e0a\u3001\u54c1\u8cea\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306e\u6700\u65b0\u5316\u3001\u30ec\u30ae\u30e5\u30e9\u30c8\u30ea\u30fc\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u5909\u9769\u306a\u3069\u306e\u30c6\u30fc\u30de\u5225\u306b40\u3092\u8d85\u3048\u308b\u30d6\u30ec\u30a4\u30af\u30a2\u30a6\u30c8\u30bb\u30c3\u30b7\u30e7\u30f3\u304c\u4e88\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4ee5\u4e0b\u306b\u305d\u306e\u4e00\u90e8\u3092\u3054\u7d39\u4ecb\u3057\u307e\u3059\u3002<\/p>\n 2020 ³Ô¹Ï±¬ÁÏ R&D Summit Europe\u306e\u30b9\u30dd\u30f3\u30b5\u30fc\u306f\u3001Accenture\u793e\u3001Base Life Sciences\u793e\u3001Deloitte\u793e\u3001Eagle Productivity\u793e\u3001Epista\u793e\u3001EY\u793e\u3001fme\u793e\u3001Inconsult\u793e\u3001LPW Training\u793e\u3001Modis\u793e\u3001Mulesoft\u793e\u3001NNIT\u793e\u3001PwC\u793e\u3001SDL\u793e\u3001Suvoda\u793e\u3001Syneos Health Consulting\u793e\u3001\u304a\u3088\u3073Valiance Partners\u793e\u3067\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ Summit\u306f\u3001³Ô¹Ï±¬ÁÏ\u306e\u304a\u5ba2\u69d8\u304a\u3088\u3073\u3054\u62db\u5f85\u5ba2\u5411\u3051\u306e\u7121\u6599\u30a4\u30d9\u30f3\u30c8\u3067\u3059\u3002\u3053\u306e\u30d0\u30fc\u30c1\u30e3\u30eb\u30a4\u30d9\u30f3\u30c8\u306e\u8a73\u7d30\u3001\u4e8b\u524d\u767b\u9332\u3001\u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u6700\u65b0\u60c5\u5831\u306b\u3064\u3044\u3066\u306f\u3001veeva.com\/EUSummit<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n <\/p>\n \u3010<\/strong>³Ô¹Ï±¬ÁÏ Systems<\/strong>\u793e\u306b\u3064\u3044\u3066\u3011<\/strong> \u3010Forward-looking Statements\u3011 \u5927\u624b\u30b0\u30ed\u30fc\u30d0\u30eb\u88fd\u85ac\u4f01\u696d\u304b\u3089\u65b0\u8208\u30d0\u30a4\u30aa\u4f01\u696d\u307e\u306770\u540d\u3092\u8d85\u3048\u308b\u30b9\u30d4\u30fc\u30ab\u30fc\u304c\u8b1b\u6f14<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-43527","post","type-post","status-publish","format-standard","hentry","category-press-release","category-case-study"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43527"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=43527"}],"version-history":[{"count":5,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43527\/revisions"}],"predecessor-version":[{"id":43534,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43527\/revisions\/43534"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=43527"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=43527"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=43527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
\n³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067\u3001850\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001https:\/\/veeva.com\/jp\/<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on F Form 10-K for the period ended January\u00a031, 2020. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"